๐ฌ Toxicology Studies in the UK – Fast, Flexible & Competitive
January 14, 2026
At Pharmidex, we offer In Vivo (Non-GLP & GLP), In Vitro, and Organ-on-Chip toxicology, alongside our full range of non-GLP and GLP toxicology studies delivered in the UK, with quick turnaround times and UK-competitive pricing.
Our experienced team supports your programme from study design through delivery, helping you generate high-quality, decision-ready data efficiently and cost-effectively.
๐ UK-based studies
โก Rapid timelines
๐ท Competitive pricing
๐งช In Vivo (Non-GLP & GLP), In Vitro & Organ-on-Chip toxicology
Learn more: www.pharmidex.com
#Toxicology #GLP #NonGLP #InVivo #InVitro #OrganOnChip #Preclinical #DrugDevelopment#UKLifeSciences #Pharmidex
At Pharmidex , we deliver industry-leading Discovery Bioanalysis services grounded in advanced LC-MS technologies to enhance drug discovery and preclinical research, supporting internal studies but also analyzing external samples also Our experienced bioanalytical team works across a wide range of therapeutic modalities, from small molecules and peptides, to oligonucleotides and complex biologics, providing robust, reliable and fit-for-purpose data to accelerate your program and strengthen decision-making during early development. We support both non-GLP and GLP/GCP workflows, method development, validation, and quantitative analysis that align with regulatory needs and industry expectations. Learn more about how our LC-MS capabilities can help you confidently advance your projects: ๐ https://www.pharmidex.com/Discovery-Bioanalysis
Today we took a short pause from the science to enjoy some well-deserved donuts together in the office. At Pharmidex , we believe culture matters just as much as capability. Moments like this simple, informal, and inclusive are part of what keeps our team connected and motivated. As a preclinical CRO, we support over 400 clients each year from our UK laboratories, delivering high-quality in vivo and bioanalytical services to advance drug discovery programmes. ๏ปฟ A small break. A strong team. Back to delivering great science. If we can support your next drug discovery project, do get in touch.
๐ง Did you know that Pharmidex offers specialist CNS preclinical services to accelerate neuroscience drug discovery? At Pharmidex, we provide expert in vivo and ex vivo neurochemistry and neurobehavioural capabilities to support the progression of CNS drug candidates across key readouts including PK, PD, target engagement and efficacy. Our CNS platform is designed to help you address the complex challenges of developing therapies for neurodegenerative and psychiatric disorders such as Alzheimer’s, Parkinson’s, schizophrenia and depression. From microdialysis and brain bioanalysis to blood–brain barrier assessment and sophisticated neurobehavioural models, we deliver actionable data to guide confident decision-making in your neuroscience programmes. Learn more about how Pharmidex can support your CNS research: ๐ www.pharmidex.com/CNS
